Imugene Limited (AU:IMU)

Imugene Limited (IMU) Financial Statements


Imugene Limited Financial Overview

Imugene Limited's market cap is currently ―. The company's EPS TTM is AU$-0.006; its P/E ratio is -8.06; Imugene Limited is scheduled to report earnings on February 28, 2024, and the estimated EPS forecast is AU$0.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 99.89MAU$ 29.49MAU$ 30.11MAU$ 19.05MAU$ 7.82M
Total AssetsAU$ 147.61MAU$ 71.81MAU$ 65.20MAU$ 30.78MAU$ 16.91M
Total DebtAU$ 673.43KAU$ 271.03KAU$ 69.34KAU$ 122.90KAU$ 0.00
Net DebtAU$ -99.21MAU$ -29.22MAU$ -30.04MAU$ -18.93MAU$ -7.82M
Total LiabilitiesAU$ 8.90MAU$ 6.79MAU$ 5.40MAU$ 3.48MAU$ 1.44M
Stockholders EquityAU$ 138.70MAU$ 65.02MAU$ 59.81MAU$ 27.29MAU$ 15.48M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Imugene Limited Earnings and Revenue History

Imugene Limited Debt to Assets

Imugene Limited Cash Flow

Imugene Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis